Zentalis Pharmaceuticals (ZNTL) EBIT (2019 - 2026)
Zentalis Pharmaceuticals' quarterly EBIT came in at -$37.9 million in Q1 2026, up 17.03% year-on-year from -$32.3 million in Q1 2025, and down 1.24% quarter-over-quarter from -$37.4 million in Q4 2025.
Zentalis Pharmaceuticals has reported EBIT for 8 years, with the latest figure at -$37.9 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 17.03% year-over-year to -$37.9 million; the trailing twelve-month figure through Mar 2026 stood at -$145.0 million (up 31.6% YoY), and the FY2025 full-year result was -$152.8 million, up 20.08% from the prior year.
- EBIT for Q1 2026 stood at -$37.9 million, down from -$37.4 million in the prior quarter.
- The five-year high for EBIT was -$24.8 million in Q1 2024, with the low at -$103.9 million in Q2 2023.
- Average EBIT over 5 years is -$53.5 million, with a median of -$51.8 million recorded in 2022.
- Year-over-year, EBIT soared 61.87% in 2024 and plunged 84.22% in 2025.
- Tracing ZNTL's EBIT over 5 years: stood at -$51.8 million in 2022, then tumbled by 31.24% to -$67.9 million in 2023, then gained by 26.61% to -$49.8 million in 2024, then gained by 24.99% to -$37.4 million in 2025, then slipped by 1.24% to -$37.9 million in 2026.
- The last three EBIT figures came in at -$37.9 million (Q1 2026), -$37.4 million (Q4 2025), and -$33.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Zentalis Pharmaceuticals | 280.35 Mn | 280.35 Mn | - | -37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.86 Mn |
| Dec 31, 2025 | -37.39 Mn |
| Sep 30, 2025 | -33.73 Mn |
| Jun 30, 2025 | -36.06 Mn |
| Mar 31, 2025 | -45.62 Mn |
| Dec 31, 2024 | -49.85 Mn |
| Sep 30, 2024 | -51.43 Mn |
| Jun 30, 2024 | -65.15 Mn |
| Mar 31, 2024 | -24.77 Mn |
| Dec 31, 2023 | -67.92 Mn |
| Sep 30, 2023 | -62.72 Mn |
| Jun 30, 2023 | -103.92 Mn |
| Mar 31, 2023 | -64.95 Mn |
| Dec 31, 2022 | -51.75 Mn |
| Sep 30, 2022 | -54.19 Mn |
| Jun 30, 2022 | -63.46 Mn |
| Mar 31, 2022 | -57.88 Mn |
| Dec 31, 2021 | -48.19 Mn |
| Sep 30, 2021 | -62.87 Mn |
| Jun 30, 2021 | -55.13 Mn |
| Mar 31, 2021 | -50.35 Mn |
| Dec 31, 2020 | -40.25 Mn |
| Sep 30, 2020 | -34.77 Mn |
| Jun 30, 2020 | -27.38 Mn |
| Mar 31, 2020 | -16.40 Mn |
| Dec 31, 2019 | -14.91 Mn |
| Sep 30, 2019 | -12.58 Mn |
| Jun 30, 2019 | -10.64 Mn |
| Mar 31, 2019 | -8.72 Mn |